ロード中...
JAK Inhibitors and Oxidative Stress Control
Primary Sjögren's syndrome (SjS) is a complex autoimmune epithelitis, with few treatment options, but the use of Janus kinase (JAK) inhibitors is promising because suppression of the JAK/signal transducer and activator of transcription (STAT) pathway improves sicca manifestations. Playing a pri...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6908489/ https://ncbi.nlm.nih.gov/pubmed/31867003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02814 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|